| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 61.5% | 8/13 |
| Female | 38.5% | 5/13 |
| Indifferent | 0% | 0/13 |
| Unknown | 0% | 0/13 |
| General | ||
| 23.1% | 3/13 | |
| 15.4% | 2/13 | |
| 30.8% | 4/13 | |
| 7.7% | 1/13 | |
| 7.7% | 1/13 | |
| 23.1% | 3/13 | |
| 69.2% | 9/13 | |
| 61.5% | 8/13 | |
| 30.8% | 4/13 | |
| 75% | 3/4 | |
| Neurology | ||
| 76.9% | 10/13 | |
| 53.8% | 7/13 | |
| 92.3% | 12/13 | |
| Facial abnormalities | ||
| 38.5% | 5/13 | |
| 84.6% | 11/13 | |
| 30.8% | 4/13 | |
| 38.5% | 5/13 | |
| Visual and hearing impairments | ||
| 7.7% | 1/13 | |
| 7.7% | 1/13 | |
| Heart | ||
| 23.1% | 3/13 | |
| Pulmonary | ||
| 23.1% | 3/13 | |
| Gastrointestinal | ||
| 38.5% | 5/13 | |
| Urogenital | ||
| 30.8% | 4/13 | |
| Skeleton | ||
| 46.2% | 6/13 | |
| Skin / Hair / Nails | ||
| 84.6% | 11/13 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/13 |
| Metabolic | 0% | 0/13 |
| 7.7% | 1/13 | |
| Neoplasia | ||
| 7.7% | 1/13 | |
| Inheritance | ||
| 100% | 13/13 | |
ODC1